ITIM
VRTX icon

Indiana Trust & Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Indiana Trust & Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Hold
35
– – ﹤0.01% 376
2026
Q1 		$15.6K Hold
35
– – ﹤0.01% 381
2025
Q4 		$15.9K Hold
35
– – ﹤0.01% 369
2025
Q3 		$13.7K Sell
35
-15
-30% -$6.27K ﹤0.01% 378
2025
Q2 		$22.3K Buy
+50
New +$23K 0.01% 339
2025
Q1 		– Sell
-20
Closed -$8.05K – 486
2024
Q4 		$8.05K Hold
20
– – ﹤0.01% 409
2024
Q3 		$9.3K Hold
20
– – ﹤0.01% 416
2024
Q2 		$9.37K Hold
20
– – ﹤0.01% 394
2024
Q1 		$8.36K Hold
20
– – ﹤0.01% 401
2023
Q4 		$8.14K Buy
+20
New +$7.39K ﹤0.01% 368

Other funds holding VRTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Indiana Trust & Investment Management's VRTX Position: Q2 2026 in Review

Indiana Trust & Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 35 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

Indiana Trust & Investment Management first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. The position peaked at $22.3K in Q2 2025. 947 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Indiana Trust & Investment Management held 35 shares of Vertex Pharmaceuticals worth $17.4K as of Q2 2026.
  • Indiana Trust & Investment Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #376 holding.
  • Indiana Trust & Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Indiana Trust & Investment Management's Vertex Pharmaceuticals position peaked at $22.3K in Q2 2025.
  • 947 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.